Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
chemical compound
|
| gptkbp:chemicalFormula |
C12H15N3O2
|
| gptkbp:compatibleWith |
75%
|
| https://www.w3.org/2000/01/rdf-schema#label |
WPC-971
|
| gptkbp:isATypeOf |
123456-78-9
|
| gptkbp:origin |
N-(4-(4-(dimethylamino)phenyl)-6-methylpyrimidin-2-yl)benzamide
|
| gptkbp:patentAssignee |
PharmaCorp
|
| gptkbp:productionCompany |
clinical trials
|
| gptkbp:releaseYear |
2010
|
| gptkbp:route |
oral
|
| gptkbp:sideEffect |
dizziness
nausea insomnia |
| gptkbp:targets |
serotonin receptor
|
| gptkbp:uses |
antidepressant
|
| gptkbp:weight |
233.27 g/mol
|